Ranolazine and Microvascular Angina by PET in the Emergency Department (RAMP-ED)

Trial Profile

Ranolazine and Microvascular Angina by PET in the Emergency Department (RAMP-ED)

Completed
Phase of Trial: Phase IV

Latest Information Update: 25 May 2017

At a glance

  • Drugs Ranolazine (Primary)
  • Indications Syndrome X
  • Focus Therapeutic Use
  • Acronyms RAMP-ED
  • Most Recent Events

    • 09 Jan 2017 Primary endpoint (Coronary Flow Reserve) has not been met,according to the results published in the clinical therapeutics.
    • 09 Jan 2017 Results published in the Clinical Therapeutics.
    • 09 Jun 2016 Status changed from recruiting to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top